Complete Response to Ibrutinib in Chronic Lymphocytic Leukemia

This ad hoc analysis of data from 2 clinical trials examines factors that may predict complete response in patients with chronic lymphocytic leukemia or small lymphocytic leukemia treated with ibrutinib.

http://ift.tt/2sLYAAX